The antitumor effects of IFN-α are abrogated in a STAT1-deficient mouse-Reference-Cited by-同舟云学术

The antitumor effects of IFN-α are abrogated in a STAT1-deficient mouse

Published:2003-07-15 Issue:2 Volume:112 Page:170-180
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Lesinski Gregory B.,Anghelina Mirela,Zimmerer Jason,Bakalakos Timothy,Badgwell Brian,Parihar Robin,Hu Yan,Becknell Brian,Abood Gerard,Chaudhury Abhik Ray,Magro Cynthia,Durbin Joan,Carson William E.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference55 articles.

1. Interferon alfa-2a for melanoma metastases

2. Interferon-alpha in tumor immunity and immunotherapy

3. High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190

4. Potential uses of interferon α2 as adjuvant therapy in cancer

5. Interferons α and β as Immune Regulators—A New Look

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic Dynamics of Multidrug Resistance Mechanisms in Lucena 1 Cell Line;Cells;2024-08-26

2. A novel oral TLR7 agonist orchestrates immune response and synergizes with PD-L1 blockade via type I IFN pathway in lung cancer;International Immunopharmacology;2024-08

3. STAT1-Deficient HPV E6/E7-Associated Cancers Maintain Host Immunocompetency against Therapeutic Intervention;Vaccines;2024-04-17

4. Inhibition of SIRT7 promotes STAT1 activation and STAT1-dependent signaling in hepatocellular carcinoma;Cellular Signalling;2024-02

5. Stat1 is an inducible transcriptional repressor of neural stem cells self-renewal program during neuroinflammation;Frontiers in Cellular Neuroscience;2023-08-16